T1	chemical 202 211	inhibitor
T2	chemical 212 223	hydralazine
T3	disease_or_phenotypic_feature 229 241	hyperthermia
T4	disease_or_phenotypic_feature 299 306	cancers
T5	chemical 328 336	platinum
T6	chemical 375 379	drug
T7	chemical 473 479	oxygen
T8	disease_or_phenotypic_feature 511 522	visual loss
T9	disease_or_phenotypic_feature 526 535	blindness
T10	chemical 567 576	inhibitor
T11	disease_or_phenotypic_feature 588 593	hyper
T12	chemical 660 667	glucose
T13	disease_or_phenotypic_feature 680 696	hyperinsulinemia
T14	chemical 711 718	glucose
T15	disease_or_phenotypic_feature 720 733	hyperglycemic
T16	disease_or_phenotypic_feature 734 750	hyperinsulinemia
T17	chemical 757 763	saline
T18	chemical 908 917	nutrients
T19	chemical 919 929	kynurenine
T20	disease_or_phenotypic_feature 945 952	obesity
T21	chemical 1020 1031	doxorubicin
T22	chemical 1067 1071	drug
T23	disease_or_phenotypic_feature 1152 1162;1173 1179	esophageal cancer
T24	chemical 1223 1235	polythiazide
T25	chemical 1243 1252	potassium
T26	chemical 1253 1260	mixture
T27	disease_or_phenotypic_feature 1281 1288	obesity
T28	chemical 1325 1340	molecular probe
T29	disease_or_phenotypic_feature 1345 1352	imaging
T30	chemical 1361 1372	Cabergoline
T31	disease_or_phenotypic_feature 1390 1408	hyperprolactinemic
T32	disease_or_phenotypic_feature 1409 1421	hypogonadism
T33	chemical 1443 1446	BCG
T34	chemical 1447 1454	mixture
T35	disease_or_phenotypic_feature 1489 1503	lung carcinoma
T36	disease_or_phenotypic_feature 1618 1633	Prostate cancer
T37	chemical 1635 1638	PCa
T38	chemical 1655 1662	biology
T39	disease_or_phenotypic_feature 1683 1689	cancer
T40	chemical 1722 1726	Acid
T41	chemical 1732 1739	balance
T42	disease_or_phenotypic_feature 1771 1784	renal failure
T43	chemical 1811 1819	Androgen
T44	disease_or_phenotypic_feature 1848 1863	prostate cancer
T45	chemical 1865 1868	PCa
T46	chemical 1972 1980	androgen
T47	chemical 2070 2077	biology
T48	disease_or_phenotypic_feature 2082 2088	cancer
T49	disease_or_phenotypic_feature 2089 2097	cachexia
T50	chemical 2100 2108	Mazindol
T51	chemical 2154 2158	food
T52	disease_or_phenotypic_feature 2169 2176	obesity
T53	chemical 2208 2215	antigen
T54	chemical 2241 2248	antigen
T55	disease_or_phenotypic_feature 2296 2302	cancer
T56	chemical 2303 2310	antigen
T57	chemical 2312 2321	Ofloxacin
T58	chemical 2338 2346	solution
T59	disease_or_phenotypic_feature 2417 2425	cataract
T60	chemical 2538 2551	nitrous oxide
T61	chemical 2560 2570	anesthesia
T62	disease_or_phenotypic_feature 2572 2585	hydrocephalus
T63	chemical 2640 2650	anesthesia
T64	chemical 2714 2724	anesthesia
T65	disease_or_phenotypic_feature 2742 2751	neoplasms
T66	chemical 2761 2768	lactose
T67	chemical 2786 2795	lactulose
T68	chemical 2806 2813	mineral
T69	disease_or_phenotypic_feature 2838 2852	hyperlipidemia
T70	disease_or_phenotypic_feature 2857 2870	hyperglycemia
T71	corrected_chemical 185 211	tumor blood flow inhibitor
T72	missed_disease_or_phenotypic_feature 11 17	tumors
R1	treats Arg1:T71 Arg2:T72	
R2	treats Arg1:T2 Arg2:T72	
R3	treats Arg1:T5 Arg2:T4	
T73	corrected_disease_or_phenotypic_feature 588 606	hyper-eosinophilia
T74	corrected_chemical 549 576	Immuno-checkpoint inhibitor
R4	causes_or_contributes_to Arg1:T74 Arg2:T73	
T75	corrected_chemical 1050 1071	chemotherapeutic drug
T76	missed_disease_or_phenotypic_feature 1119 1145	inhibition of tumor growth
R5	causes_or_contributes_to Arg1:T21 Arg2:T76	
R6	causes_or_contributes_to Arg1:T75 Arg2:T76	
R7	treats Arg1:T21 Arg2:T23	
R8	treats Arg1:T75 Arg2:T23	
T77	corrected_chemical 1208 1260	combination of polythiazide with a potassium mixture
R9	treats Arg1:T77 Arg2:T27	
T78	corrected_disease_or_phenotypic_feature 1390 1421	hyperprolactinemic hypogonadism
R10	treats Arg1:T30 Arg2:T78	
R13	causes_or_contributes_to Arg1:T43 Arg2:T44	
T81	missed_disease_or_phenotypic_feature 1865 1868	PCa
R14	causes_or_contributes_to Arg1:T43 Arg2:T81	
T82	corrected_disease_or_phenotypic_feature 2154 2176	food-dependent obesity
R15	treats Arg1:T50 Arg2:T82	
T83	missed_chemical 2110 2117	Teronac
R16	treats Arg1:T83 Arg2:T82	
T84	missed_disease_or_phenotypic_feature 2479 2493	pneumocephalus
R17	causes_or_contributes_to Arg1:T60 Arg2:T84	
T85	missed_chemical 2553 2558	N(2)O
R18	causes_or_contributes_to Arg1:T85 Arg2:T84	
T86	corrected_chemical 2761 2784	lactose-based prebiotic
T87	missed_disease_or_phenotypic_feature 2806 2824	mineral absorption
R19	causes_or_contributes_to Arg1:T86 Arg2:T87	
R20	causes_or_contributes_to Arg1:T67 Arg2:T87	
R21	treats Arg1:T86 Arg2:T69	
R22	treats Arg1:T67 Arg2:T69	
R23	treats Arg1:T86 Arg2:T70	
R24	treats Arg1:T67 Arg2:T70	
T88	corrected_chemical 651 667	duodenal glucose
T89	corrected_disease_or_phenotypic_feature 669 696	euglycemic hyperinsulinemia
R25	causes_or_contributes_to Arg1:T88 Arg2:T89	
T90	corrected_chemical 699 718	intravenous glucose
T91	corrected_disease_or_phenotypic_feature 720 750	hyperglycemic hyperinsulinemia
R26	causes_or_contributes_to Arg1:T90 Arg2:T91	
T92	missed_disease_or_phenotypic_feature 611 626	tumor shrinkage
R27	causes_or_contributes_to Arg1:T74 Arg2:T92	
